Abstract

This study explores the evolving landscape of managing Eisenmenger Syndrome by examining the advancements in inhaled nitric oxide (iNO) strategies. With a focus on optimizing oxygenation, we delve into the efficacy, safety, and potential benefits of incorporating iNO in the treatment regimen. By reviewing recent developments and clinical outcomes, this research contributes to a deeper understanding of how inhaled nitric oxide can play a pivotal role in enhancing oxygenation and improving the quality of life for individuals with Eisenmenger Syndrome.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.